Greenlane Renewables (GRN.TO) on Wednesday said it secured C$2.5 million in equipment and service contracts from an existing customer with a portfolio of renewable natural gas producing assets in the United States.
The awards include the purchase of Greenlane's proprietary Cascade hydrogen-sulfide (H2S) biogas desulfurization system and an independent service work order, it said.
"Every biogas-to-RNG project requires H2S treatment removal. This sale supports our strategy to establish market leadership in the Americas with Cascade H2S and reflects growing customer confidence in the value proposition of the product," chief executive Brad Douville said.
Shares of the company were last seen up C$0.01, or 4.5%, to C$0.23 on the Toronto Stock Exchange.
Price: $0.23, Change: $+0.01, Percent Change: +4.55%